Irritable bowel syndrome (IBS)
Older patients are particularly susceptible to the antimuscarinic effects of antispasmodics.
135mg 3 times daily preferably 20 minutes before meals.
135mg 3 times daily preferably 20 minutes before meals.
20mg 4 times daily.
Initially by intramuscular injection, or by slow intravenous injection. 20mg, then (by intramuscular injection or by slow intravenous injection) 20mg after 30 minutes if required, dose may be repeated more frequently in endoscopy; maximum 100mg per day.
1-2 capsules 3 times a day for up to 2-3 months if necessary, dose to be taken before meals, swallowed whole with water.
Prescribing Notes:
- Antispasmodics are of limited benefit but are occasionally used for acute exacerbations of irritable bowel syndrome. They should be used in conjunction with other measures such as reassurance, diet, fluid intake, exercise, bulking agents and lifestyle modifications.
- Antimuscarinics relax the oesophageal sphincter and should be used with caution in patients with symptoms of reflux.
- Peppermint oil capsules should be reserved for patients presenting with symptoms of bloating.
- Peppermint oil capsules should not be chewed as they can cause irritation to mouth and/or oesophagus, causing symptoms of heartburn.
History Notes
15/12/2021
East Region Formulary content agreed.
Consider the use of amitriptyline.
Initially 5-10mg daily, to be taken at night; increased in steps of 10mg at least every 2 weeks as required; maximum 30mg per day.
10mg-30mg per day maximum, titrated in 10mg increments.
10mg-30mg per day maximum, titrated in 10mg increments.
History Notes
15/12/2021
East Region Formulary content agreed.
See prescribing notes, ispaghula husk may be considered.
For dose, refer to BNF for Children.
For dose, refer to BNF for Children.
For dose, refer to BNF for Children.
Prescribing Notes:
- Treatment of IBS is focused on symptom control in order to improve quality of life, including minimising abdominal pain and normalising the frequency and consistency of stools.
- There is no evidence of the effectiveness of any form of dietary advice or increased fibre intake in children and it is not known whether dietary advice recommended to adult patients is of benefit to children.
- Eating regularly, limiting fresh fruit intake, and, reducing intake of ‘resistant starch’ and insoluble fibre (e.g. bran) can be recommended. If an increase in dietary fibre is required, soluble fibre such as oats, ispaghula husk, or sterculia can be recommended. Ensuring a sufficient intake of fluids can also be recommended.
- In Lothian additional information is available on RefHelp for Irritable Bowel Syndrome (IBS) and Functional Abdominal Pain (FAP).
History Notes
30/08/2023
East Region Formulary content agreed - ERFC 09/08/2023.
Mebeverine oral suspension should only be used when patients cannot tolerate or use solid formulations.
For dose, refer to BNF for Children.
For dose, refer to BNF for Children.
For dose, refer to BNF for Children.
For dose, refer to BNF for Children.
For dose, refer to BNF for Children.
Prescribing Notes:
- Antispasmodics are of limited benefit but are occasionally used for acute exacerbations of irritable bowel syndrome. They should be used in conjunction with other measures such as reassurance, diet, fluid intake, exercise, bulking agents and lifestyle modifications.
- In Lothian additional information is available on RefHelp for Irritable Bowel Syndrome (IBS) and Functional Abdominal Pain (FAP).
History Notes
30/08/2023
East Region Formulary content agreed - ERFC 09/08/2023.
Dose according to age and product licence.
History Notes
15/12/2021
New pathway created to align to 01/10/2021 NHS Pharmacy First Scotland - Approved List of Products.
Dose according to age and product licence.
Prescribing Notes:
- These products should not be supplied if the patient is presenting with IBS symptoms for the first time.
- NICE CG 61 notes that antispasmodics should be taken as required, alongside dietary and lifestyle advice.
When to advise patient to contact GP
Patients with new onset of symptoms or worsening symptoms.
Symptoms suggestive of underlying disease e.g. blood in stools, unexplained weight loss, major change in bowel habit, anaemia-like symptoms.
Unresponsive to appropriate treatment.
History Notes
27/10/2020
Content migrated from ‘East Region Formulary: Pharmacy First - supporting minor ailments’ document.